arrow
I

Ignacio Gil-Bazo

CIMA Universidad de Navarra
H指数:39
被引数:5,084

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data

基于真实世界数据,监测外周血数据支持对晚期非小细胞肺癌免疫治疗反应的预测。

2025-02-250
OA
Preventing Infusion-Related Reactions With Intravenous Amivantamab—Results From SKIPPirr, a Phase 2 Study: A Brief Report

预防静脉注射Amivantamab相关反应:SKIPPirr一项2期研究的成果——简报

2025-01-240
OAAI
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab
2024-08-064
OAAI
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

曲美替尼通过Id1下调使KRAS突变型肺腺癌肿瘤对PD-1/PD-L1轴阻滞敏感

2024-04-201
OAAI
Trial in progress: A phase I, open-label, multicenter study of ZL-1218, an anti-CCR8 IgG1, as a single agent and as combination therapy with anti-PD-1 antibody to evaluate the safety, tolerability, and pharmacokinetics in subjects with advanced solid tumor
2024-04-050
PRE
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Nature
IF48.5
2024-02-280
OAAI
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
2023-12-011
PRE
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
2023-10-109
OAAI
Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockade
2023-04-040
PRE
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients

纵向深度放射组学和临床数据的整合改善了晚期NSCLC患者对anti-PD-1/PD-L1免疫治疗的持久益处的预测

2023-03-0518
OAAI
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations
2022-08-0131
OAAI
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
2022-03-0161
PRE
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) (vol 151, 102978, 2020)
2020-10-010
PREAI
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
2020-07-0189
PRE